The Latin America, Middle East and Africa AI In Cancer Diagnostics Market should witness market growth of 32.5% CAGR during the forecast period (2022-2028).
In the detection of cancer, the Imaging process is used for developing precise photos of the body's organs and structure. The imaging is also used to identify the abnormalities, condition, and location of the tumor. It can be utilized in various procedures such as biopsies and surgeries. Reflecting imaging, emission imaging, and transmission imaging are the three various types of imaging utilized in diagnosing cancer. X-rays, CT scans, and fluoroscopy images are sent from radiological exams.
Additionally, many other researchers can quickly determine the subtype of cancer by uploading methylation profiles into research which also delivers a confidence level that indicates the probability that the result is precise. As per the German neuropathologist, Andreas von Deimling, moreover about 1000 such reports are submitted each year.
As the United Arab Emirates (UAE) is becoming one of the fastest-growing economies the number of patients related to chronic diseases like cancer is also increasing. Even after the initial detection efforts and screening the number of registered cases and fatalities in UAE has increased significantly, this can be attributed to the fact that the coverage of people is less than the targeted population.
The Brazil market dominated the LAMEA AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $8.5 million by 2028. The Argentina market is showcasing a CAGR of 33.2% during (2022-2028). Additionally, The UAE market would register a CAGR of 32.1% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
In the detection of cancer, the Imaging process is used for developing precise photos of the body's organs and structure. The imaging is also used to identify the abnormalities, condition, and location of the tumor. It can be utilized in various procedures such as biopsies and surgeries. Reflecting imaging, emission imaging, and transmission imaging are the three various types of imaging utilized in diagnosing cancer. X-rays, CT scans, and fluoroscopy images are sent from radiological exams.
Additionally, many other researchers can quickly determine the subtype of cancer by uploading methylation profiles into research which also delivers a confidence level that indicates the probability that the result is precise. As per the German neuropathologist, Andreas von Deimling, moreover about 1000 such reports are submitted each year.
As the United Arab Emirates (UAE) is becoming one of the fastest-growing economies the number of patients related to chronic diseases like cancer is also increasing. Even after the initial detection efforts and screening the number of registered cases and fatalities in UAE has increased significantly, this can be attributed to the fact that the coverage of people is less than the targeted population.
The Brazil market dominated the LAMEA AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $8.5 million by 2028. The Argentina market is showcasing a CAGR of 33.2% during (2022-2028). Additionally, The UAE market would register a CAGR of 32.1% during (2022-2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Scope of the Study
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA AI In Cancer Diagnostics Market by End-user
Chapter 5. LAMEA AI In Cancer Diagnostics Market by Component
Chapter 6. LAMEA AI In Cancer Diagnostics Market by Cancer Type
Chapter 7. LAMEA AI In Cancer Diagnostics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Methodology
LOADING...
